Clinical Trial Update: A Study Evaluating Toripalimab Injection Combined With Standard Chemotherapy as a First-line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating toripalimab plus standard chemotherapy as first-line treatment for locally advanced or metastatic urothelial carcinoma is in progress…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Or Metastatic Urothelial Carcinoma

Drugs mentioned

• Standard chemotherapy
• Toripalimab (Toripalimab)

Snippet

Sponsor: Shanghai Junshi Bioscience Co., Ltd. | Conditions: Locally Advanced or Metastatic Urothelial Carcinoma | Phase 3 | Status: UNKNOWN